首页|CT增强扫描药物应用分析

CT增强扫描药物应用分析

扫码查看
目的 观察CT增强扫描中静脉注射造影剂导致药物渗出的因素,分析其应对措施.方法 抽取2016年1月~2017年6月间在建德市第一人民医院行CT增强扫描中出现药物渗出的61例患者为研究对象,通过对本组患者静脉注射造影剂后药物渗出因素予以观察并记录,以此分析应对措施.结果 本组患者药物外渗因素主要为:≥12岁者发生率为63.93%(39/61);注射流速3.0~4.0 mL/s发生率为70.49%(42/61);注射血管中前臂小静脉80.33%(49/61);渗透压≥300 mOsm/kg H2O发生率为83.61%(51/61).结论 CT增强扫描中导致静脉注射造影剂药物渗出的因素呈多样化,需根据患者药物渗出特异性选择针对性措施干预,可有效改善患者肿胀、血瘀、疼痛等临床指征,具有重要实用价值.
Analysis of CT enhanced scanning drugs
Objective To investigate the factors causing exudation of drugs by intravenous contrast medium in CT enhanced scan, and to analyze the corresponding measures. Methods From January 2016 to June 2017 in the First People's Hospital of Jiande City 61 cases of drug extravasation enhanced CT scanning in patients as the research object, through the observation of the drug leakage factors to agents in this group of patients with intravenous contrast and record, in order to find out measures. Results The statistics show, this group of patients with drug extravasation factors: 12 years of age, the incidence rate was 63.93% (39/61) injection velocity; the incidence rate of 3.0~4.0ml/s was 70.49% (42/61);small vein injection of vascular forearm 80.33% (49/61); osmotic pressure, the incidence rate of 300mOsm/kgH2O was 83.61% (51/61). Conclusion CT scan causes intravenous contrast agent oozing drugs are various, according to the specific selection of patients with drug exudation measures, can effectively improve the patients clinicalcharacteristics of blood stasis, swelling, pain, and has important practical value.

CT enhanced scanintravenous injection of contrast agentsdrug exudationnursing intervention

李文婷、叶俊

展开 >

建德市第一人民医院 放射科,浙江 建德 311600

CT增强扫描 静脉注射造影剂 药物渗出 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(9)
  • 1
  • 8